Zydus Cadila receives USFDA nod for manufacturing Doxycycline injection
Zydus Cadila receives USFDA nod for manufacturing Doxycycline injection

Zydus Cadila receives USFDA nod for manufacturing Doxycycline injection

DSIJ Intelligence Article rating: 4.1

On Thursday, pharma company Zydus Cadila announced that it has received approval from United States Food and Drug Administration (USFDA) for its supplemental abbreviated new drug application (SANDA) for Doxycycline Injection USP, 100mg/vial.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 3.7

The market opened in the green on July 16, 2020, overall volumes in futures & options currently stand at 3,53,96,076 crore contracts with a turnover of Rs. 21,50,273.38 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 4.0

The market opened in the green on July 16, 2020, overall volumes in futures & options currently stand at 3,53,96,076 crore contracts with a turnover of Rs. 21,50,273.38 crore.

DoT withdraws AGR dues demand notices on GAIL & Power Grid
DoT withdraws AGR dues demand notices on GAIL & Power Grid

DoT withdraws AGR dues demand notices on GAIL & Power Grid

Apurva Joshi Article rating: 4.3

Department of Telecommunications (DoT), Ministry of Communications and Government of India has withdrawn provisional demand notices issued on GAIL Limited and Power Grid Corporation of India Limited. The dues were related to adjusted gross revenue (AGR) imposed over the telecom revenues earned by these companies.

Cochin Shipyard secures electrical vessel building contract
Cochin Shipyard secures electrical vessel building contract

Cochin Shipyard secures electrical vessel building contract

Nidhi Jani Article rating: 5.0

This project would further enhance Cochin Shipyard’s presence into the division of premier shipbuilding yards with a capacity to handle hi-tech vessel construction. Looking at the current order book position, it stood at Rs 14,630 crore, which provides healthy revenue visibility. 

RSS
First29482949295029512953295529562957Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR